Porunelloor A. Mathew
Affiliations: | Microbiology and Immunology | University of North Texas Health Science Center at Fort Worth |
Area:
ImmunologyGoogle:
"Porunelloor Mathew"Children
Sign in to add traineeKent S. Boles | grad student | 2001 | University of North Texas Health Science Center at Fort Worth |
Swapnil V. Vaidya | grad student | 2005 | University of North Texas Health Science Center at Fort Worth |
Prachi Dongre | grad student | 2012 | University of North Texas Health Science Center at Fort Worth |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Marrufo AM, Mathew SO, Chaudhary P, et al. (2023) Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells. American Journal of Cancer Research. 13: 1082-1090 |
Powers SB, Ahmed NG, Jose R, et al. (2023) Differential Expression of LLT1, SLAM Receptors CS1 and 2B4 and NCR Receptors NKp46 and NKp30 in Pediatric Acute Lymphoblastic Leukemia (ALL). International Journal of Molecular Sciences. 24 |
Malaer JD, Mathew PA. (2020) Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells. Anticancer Research. 40: 6613-6621 |
Buller CW, Mathew PA, Mathew SO. (2020) Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer. Cancers. 12 |
Malaer JD, Marrufo AM, Mathew PA. (2018) 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer. Clinical Immunology (Orlando, Fla.) |
Marrufo AM, Mathew SO, Chaudhary P, et al. (2018) Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. American Journal of Cancer Research. 8: 1050-1063 |
Bowen KE, Mathew SO, Borgmann K, et al. (2018) A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells. Plos One. 13: e0193008 |
Malaer JD, Mathew PA. (2017) CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. American Journal of Cancer Research. 7: 1637-1641 |
Mathew SO, Chaudhary P, Powers SB, et al. (2016) Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction. Oncotarget |
Kim JR, Mathew SO, Mathew PA. (2015) Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells. Immunobiology |